The present study assessed the effects of an AT 1 R antagonist (losartan) on preventing hyperoxia-induced lung fibrosis in newborn rats. Rat pups were exposed to seven days of >95
Introduction
Bronchopulmonary dysplasia (BPD) remains a major cause of morbidity and mortality during the first year of life. Many infants have significant respiratory problems throughout childhood, including increased airway reactivity and development of obstructive airway disease (Lemons, 1996) . Some abnormal lung functions may persist into adulthood (Northway, 1990) . The pathogenesis of BPD is multifactorial, and researchers believe pulmonary oxygen toxicity may play an important role in the lung injury process, which leads to the development of BPD (Welty, 2001) . In previous studies, prolonged exposure of neonatal mice to hyperoxia resulted in decreased alveolar septation, increased terminal air space size, and increased lung fibrosis in a similar manner to human BPD (Manji et al., 2001; Couroucli et al., 2006; Chen et al., 2007) . Currently no effective therapy is clinically available to prevent long-term pulmonary sequelae of BPD.
The renin-angiotensin system (RAS) is a key regulator of blood pressure and fluid homeostasis (Peach, 1977; Morrey et al., 2010) . Angiotensin (Ang) II is a main effector molecule of the RAS, produced from the substrate angiotensinogen through sequential enzymatic cleavages by renin and angiotensin-converting enzyme. Tissues throughout the body synthesize various components of the RAS, which may be subject to local control (Dzau, 1987; Veerappan et al., 2008) . A previous investigation reported high Ang II concentrations in normal rat lung (Tryka, 1986) . Another prior study identified angiotensinogen and Ang II This article has not been copyedited and formatted. The final version may differ from this version. JPET Fast Forward. Published on October 17, 2011 as DOI: 10.1124 at ASPET Journals on July 11, 2017 jpet.aspetjournals.org Downloaded from type 1 receptor (AT 1 R) expression in rat lung tissue (Campbell, 1995) . Ang II is a potential profibrotic mediator, inducing human lung fibroblast proliferation via activation of the AT 1 R and stimulating collagen synthesis in human lung fibroblasts (Marshall et al., 2000; Marshall et al., 2004) . The present group previously demonstrated that hyperoxia increased the expression of collagen and RAS components in human lung fibroblasts (Lang et al., 2010) .
The AT 1 R antagonist losartan and AT 1 R siRNA diminished the hyperoxia-increased collagen expression. However, the AT 2 R antagonist PD123319 did not have any effects on these hyperoxia-induced changes. The in vivo therapeutic potential of AT 1 R antagonists in hyperoxia-induced lung fibrosis remains unknown. The aim of this study, therefore, was to test if an AT 1 R antagonist would attenuate hyperoxia-induced lung fibrosis in newborn rats.
Materials and Methods
Animals. This study was performed in accordance with the guidelines provided by the Animal Care Use Committee of Taipei Medical University. A total of eight time-dated pregnant Sprague-Dawley rats were housed in individual cages with free access to laboratory food and water ad libitum, kept in a 12:12 h light-dark cycle, and allowed to deliver vaginally at term. Four pregnant dams were assigned to both room air and hyperoxia groups.
Hyperoxia Exposure. Within 12 h of birth, litters were separated from their mothers, pooled before being randomly redistributed to the newly delivered mothers, and exposed to >95 % O 2 or room air (Fig. 1) . Rat pups were injected intraperitoneally with losartan This article has not been copyedited and formatted. The final version may differ from this version. JPET Fast Forward. Published on October 17, 2011 as DOI: 10.1124 at ASPET Journals on July 11, 2017 jpet.aspetjournals.org Downloaded from (Sigma-Aldrich, St. Louis, MO, USA) at a dose of 10 mg/kg/day from postnatal days one to seven, and 5 mg/kg/day from postnatal days eight to 21. The dosage of losartan was based on recommendations by Li et al., 2003 . Control groups were injected with an equal volume of normal saline. Nursing mothers were rotated between oxygen exposed and room air litters every 24 h to avoid oxygen toxicity in the mothers and to eliminate maternal effects between groups. Oxygen exposures were performed in transparent 40 X 50 X 60 cm Plexiglas chambers, into which oxygen was continuously delivered at 4 l/min and oxygen levels were monitored using a Pro:ox Model 110 monitor (BioSpherix, Redfield, NY, USA). Litters were exposed to seven days of >95 % O 2 and then allowed to recover from the acute injury in a continuing environment of moderate hyperoxia (60 % O 2 ) for a further two weeks (three weeks of total hyperoxia). Body and lung weights were recorded at the time of sacrifice. Animals were killed by an intraperitoneal injection of pentobarbital sodium and were exsanguinated by aortic transection. Lung tissue from room air-and hyperoxia-exposed pups was harvested on postnatal days seven and 21.
Real-Time Polymerase Chain Raction (PCR).
Total RNA was extracted using the TRIzol reagent (Invitrogen, Carlsbad, CA, USA). Complementary DNA (cDNA) was synthesized with a First-Strand cDNA Synthesis Kit (GE Healthcare, Piscataway, NJ, USA).
Primer sequences for real-time PCR were collagen type I sense 5'-CAACCTCAAGAAGTCCCTGC-3', antisense 5'-AGGTGAATCGACTGTTGCCT-3'; This article has not been copyedited and formatted. The final version may differ from this version. JPET Fast Forward. Published on October 17, 2011 as DOI: 10.1124 at ASPET Journals on July 11, 2017 jpet.aspetjournals.org Downloaded from alpha smooth muscle actin (α-SMA) sense 5'-GCTCTGGTGTGTGACAATGG-3', antisense 5'-CACGATGGATGGGAAAACAG-3'; GAPDH sense 5'-CTCCCTCAAGATTGTCAGCAA-3', antisense 5'-GTCAGATCCACAACGGATACATT-3'. Gene expression was quantitatively analyzed using the comparative CT (ΔCT) method, in which CT is the threshold cycle number (the minimum number of cycles needed before the product can be detected). The arithmetic formula for the Δ CT method is the difference in threshold cycles for a target and an endogenous reference (the GAPDH housekeeping gene). The amount of target normalized to an endogenous reference and relative to a calibration normalized to an endogenous reference is given by 2ΔΔCT. The sampled tissues were dehydrated in alcohol, cleared in xylene, and embedded in paraffin.
Measurement of Total
Seven µm tissue sections were stained with hematoxylin and eosin (H&E), and examined by a pathologist who was blinded to the protocol and experimental groups. Five random high power (×400) fields were evaluated by the presence of hemorrhage, alveolar septal thickness, and inflammatory cell infiltration, using a scale of 0-4. The macrophage numbers of each section were determined by counting five random fields at ×400 magnification. The number of macrophages was averaged for each group and compared statistically. Other lung sections were stained with Masson's trichrome and assessed for the presence of collagen. The selected sections were viewed and photographed using a 10× objective lens and a Nikon Eclipse E600 microscope. A minimum of four randomly selected fields were captured at ×100 magnification for each section using a digital camera and imported into a computerized image analysis system (Image-Pro Plus 5.1 for Windows, Media Cybernetics, Silver Spring, MD, USA). The automatic object density process was used for quantification of collagen accumulation in the lung tissue.
Statistical Analysis. Results are presented as the mean ± S.D. Analysis of differences between the two groups on each postnatal day was evaluated using one-way analysis of variance (ANOVA) with post-hoc Scheffe's test. Survival rate was evaluated using the Kaplan-Meier method and the log-rank test was used for comparisons between treatment groups. Differences were considered significant at P < 0.05.
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Results
Body Weight, Lung Weight, and the Lung/Body Weight Ratio (%). Tables 1 and 2 present the effects of hyperoxia and losartan treatment on body weight, lung weight, and the lung/body weight ratio (%) on postnatal days seven and 21, respectively. Body weights and lung weights increased as rats aged. Rats exposed to hyperoxia exhibited significantly lower body weights and lower lung weights when compared with room-air controls on postnatal days seven and 21, and the values were comparable between vehicle-and losartan-treated rats.
The lung/body weight ratio was smaller in hyperoxia-exposed rats on postnatal day seven and significantly larger in hyperoxia-exposed rats when compared with room-air controls on postnatal day 21. Body weight, lung weight, and the lung/body weight ratio were comparable between vehicle-and losartan-treated rats in room air and hyperoxia groups on postnatal days seven and 21.
Survival. Hyperoxia decreased survival rate, mainly on postnatal day 7, reaching 70% in the hyperoxia + vehicle group ( Figure 2 ). Losartan treatment increased hyperoxia-decreased survival rate to 80%. The differences in survival rate between newborn rats treated by losartan under hyperoxia and those under room air and receiving either vehicle or losartan were not significant.
Histology. Figure 3 presents representative lung sections from room air-and hyperoxia-exposed rats. Room air-exposed animals treated with the vehicle or losartan This article has not been copyedited and formatted. The final version may differ from this version. showed normal lung structure on postnatal day seven, and there was no evidence of tissue injury (Fig. 3A, a and b) . On postnatal day seven, the lungs of the hyperoxia-exposed rats contained larger, more thin-walled air spaces when compared with room air-exposed rats (Fig. 3A, c and d; Table 3 ). The changes in the histologic scores in the categories of hemorrhage and interstitial inflammation were not statistically significant on postnatal day seven (Table 3) .
On postnatal day 21, the lungs of hyperoxia-exposed rats contained more hemorrhage and wide interstitium with inflammatory cell recruitment compared with room air-exposed animals ( Fig. 3B ; Table 4 ). Hyperoxia treatment of newborn rats significantly increased lung macrophage number compared to room air-exposed rats and losartan treatment decreased macrophage number on postnatal days seven and 21 (Table 3 and 4). (Fig. 6 ). Hyperoxia-exposed rats had widespread collagen deposition in both peribronchial and parenchymal portions of the lung. In contrast, the collagen deposition in hyperoxia-exposed and losartan-treated rats was significantly attenuated. (Fig. 7, A and B) . This indicated the presence of hyperoxia-induced pulmonary fibrosis in the newborn rats. Hyperoxic exposure for seven days significantly increased collagen type I and ERK 1/2 protein expression compared to room air-exposed rats (Fig. 7, A (Tables 1 and 2 ) and the histological evidence of lung damage on postnatal day seven ( Fig. 2) were consistent with previous studies showing acute lung injury in newborn rats exposed to prolonged hyperoxia (Couroucli et al., 2006; Chen et al., 2007) . This study tested the hypothesis that an AT 1 R antagonist would attenuate hyperoxia-induced lung fibrosis in newborn rats. The main finding of this study is that the AT 1 R antagonist losartan attenuated hyperoxia-induced lung fibrosis. This protection of lung fibrosis by losartan treatment (Figs. 3-4) was consistent with the hypothesis that losartan protects newborn rats from lung fibrosis induced by oxygen. These results suggest that AT 1 R plays a significant role in the pathogenesis of hyperoxia-induced lung fibrosis.
Effects of Hyperoxia on

AT 1 R antagonist at the dose of 7.5 mg/kg for 8 weeks did not influence systolic blood pressure in the normotensive rats and losartan at a dose of 10 mg/kg completely prevented collagen gene activation and attenuated the degree of renal vascular fibrosis without influencing the systolic blood pressure in the transgenic mice (Takemoto et al., 1997; Boffa et al., 1999) . Other potential actions by which AT 1 R antagonists might act on the lung include decreased vascular tone, decreased vascular permeability, and altered fibroblast activity (Marshall, 2003) . Thus, it is probable that anti-fibrotic action of losartan might be related to lower systemic blood pressure. However, blood pressure was not measured in the present study and the data do not exclude that possibility.
The alveolar stage of lung development in the mouse begins on postnatal day four, and (Burri, 1974) . The newborn rat is particularly appropriate for studies of neonatal oxygen injury because the developmental stage of the rodent lung at birth overlaps with that of the human preterm neonate at 24 to 28 weeks' gestation (Han et al., 1996) . During the study's three week period of hyperoxia, the body weight of the hyperoxia-exposed rats reduced to ~80 % and ~35 % of the body weight of the room air-exposed rats on postnatal days seven and 21, respectively (Tables 1 and 2 ). The lung weight of hyperoxia-exposed rats also significantly decreased when compared to the room-air groups. In hyperoxia-exposed rats, loss of body weight was proportionally greater than lung weight loss, resulting in an increased lung to body weight ratio on postnatal day 21. The trends in changes to body weight and lung weight are similar to the group's previous hyperoxia study (Chen et al., 2007) . Body weight, lung weight, and the lung/body weight ratio were comparable between vehicle-and losartan-treated rats in room air and hyperoxia groups on postnatal days seven and 21. These results indicate that losartan treatment had no effects on body weight, lung weight, or the lung/body weight ratio of room air-or hyperoxia-exposed rats.
Hyperoxia-induced lung injury is characterized by death of cells. Increased proliferation
and differentiation of fibroblasts replaces these cells (Tryka et al., 1986) . Failure to modify these processes may lead to excessive cell growth and proliferation, collagen overproduction, and pulmonary fibrosis. Collagen is the major extracellular matrix component of the lungs Figure 4 . Increased collagen deposition in the interstitum and inter-alveolar septum occurred in hyperoxia-exposed rats when compared to room air-exposed rats on postnatal days seven and 21 (Fig. 4, A and B) . In contrast, hyperoxia-exposed and losartan-treated rats exhibited significantly less collagen deposition compared to room air-and hyperoxia-exposed and vehicle-treated rats.
This study demonstrated that hyperoxia increased p-ERK expression (Fig. 5 ).
This article has not been copyedited and formatted. The final version may differ from this version. The group's previous study demonstrated that ERK 1/2, but not p38 MAPK, is involved in the hyperoxia-induced increase of collagen type I in human lung fibroblasts (Lang et al., 2010) .
The present in vivo study identified augmentation of ERK 1/2 subsequent to hyperoxic exposure on postnatal days seven (a ~two-fold increase) and 21 (a ~four-fold increase). The AT 1 R antagonist losartan decreased the hyperoxia-induced ERK 1/2 protein expression.
These results suggest the involvement of ERK1/2 in hyperoxia-induced lung fibrosis.
In conclusion, this study further confirms the functional significance of RAS signaling in the pathogenesis of hyperoxia-induced lung injury and the therapeutic potential of AT 1 R antagonists in protecting against hyperoxia-induced lung fibrosis. This study also reveals that an AT 1 R antagonist does not have deleterious effects on normal neonatal lung development.
Currently no effective therapy is clinically available to prevent hyperoxia-induced lung fibrosis. AT 1 R antagonist therapy may provide a novel strategy to prevent hyperoxia-induced lung fibrosis.
This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version. Fig. 2 . Effects of losartan on survival rate in room air-and hyperoxia-exposed rats. Newborn rats were exposed to room air or hyperoxia and treated with vehicle or losartan as described in
Materials and Methods. Kaplan-Meier curve representation of survival of newborn rats exposed to room air or hyperoxia (circles and rectangles, respectively), and either treated with vehicle (open symbols) or receiving losartan (closed symbols). a denotes significant differences from room air-exposed group curve at P < 0.01. Fig. 3 . Morphology of representative lung sections from room air-and hyperoxia-exposed rats (H&E, ×100). Newborn rats were exposed to room air or hyperoxia and treated with vehicle or losartan as described in Materials and Methods. Animals were sacrificed on postnatal day seven (A) or 21 (B). a, room air-exposed rats treated with vehicle; b, room air-exposed rats treated with losartan; c, hyperoxia-exposed rats treated with vehicle; and d, hyperoxia-exposed rats treated with losartan. post-hoc Scheffe's test, were used to evaluate the statistical significance of differences between individual groups. a denotes significant differences from room air + vehicle at P < 0.05. b denotes significant differences from room air + vehicle, room air + losartan, and hyperoxia + losartan at P < 0.01. c denotes significant differences from room air + vehicle, room air + losartan, and hyperoxia + losartan at P < 0.05. Fig. 5 . Effects of losartan on total collagen contents in room air-and hyperoxia-exposed rats.
Newborn rats were exposed to room air or hyperoxia and treated with vehicle or losartan as . One-way ANOVA, followed by post-hoc Scheffe's test, were used to evaluate the statistical significance of differences between individual groups. a denotes significant differences from room air + vehicle, room air + losartan, and hyperoxia + losartan at P < 0.001. Fig. 6 . Effects of losartan on collagen density in room air-and hyperoxia-exposed rats.
Newborn rats were exposed to room air or hyperoxia and treated with vehicle or losartan as used to evaluate the statistical significance of differences between individual groups. a denotes significant differences from room air + vehicle, room air + losartan, and hyperoxia + losartan at P < 0.001. b denotes significant differences from room air + vehicle, room air + losartan, and hyperoxia + losartan at P < 0.01. TABLE 1 Body weight, lung weight, and the lung/body weight ratio in room air-and hyperoxia-exposed rats on postnatal day seven.
Newborn rats were exposed to room air or hyperoxia and treated with vehicle or losartan as b Different from room air-exposed rats at P < 0.01.
c Different from room air + losartan group at P < 0.05.
This article has not been copyedited and formatted. The final version may differ from this version. TABLE 3 Lung histological features in room air-and hyperoxia-exposed rats on postnatal day seven.
Newborn rats were exposed to room air or hyperoxia and treated with vehicle or losartan as a Different from room air-exposed rats at P < 0.001.
b Different from room air-exposed rats and hyperoxia + losartan group at P < 0.001.
This article has not been copyedited and formatted. The final version may differ from this version. TABLE 4 Lung histological features in room air-and hyperoxia-exposed rats on postnatal day 21.
Newborn rats were exposed to room air or hyperoxia and treated with vehicle or losartan as a Different from room air-exposed rats and hyperoxia + losartan group at P < 0.05.
b Different from room air-exposed rats and hyperoxia + losartan group at P < 0.01.
